IGM Biosciences Inc (IGMS)
9.40
+1.75
(+22.88%)
USD |
NASDAQ |
Apr 26, 16:00
9.41
+0.01
(+0.11%)
After-Hours: 20:00
IGM Biosciences Profit Margin (Quarterly): -9.32K% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -9.32K% |
| September 30, 2023 | -12.18K% |
| June 30, 2023 | -14.38K% |
| March 31, 2023 | -11.36K% |
| Date | Value |
|---|---|
| December 31, 2022 | -14.13K% |
| September 30, 2022 | -17.53K% |
| June 30, 2022 | -16.01K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-17.53K%
Minimum
Sep 2022
-9.32K%
Maximum
Dec 2023
-13.56K%
Average
-14.13K%
Median
Dec 2022
Profit Margin (Quarterly) Benchmarks
| Inotiv Inc | -11.36% |
| Synlogic Inc | -524.9% |
| BioXcel Therapeutics Inc | -5.92K% |
| Xilio Therapeutics Inc | -- |
| NovaBay Pharmaceuticals Inc | -110.2% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -99.17% |
| Return on Assets | -52.33% |
| Return on Invested Capital | -99.17% |
| Operating Margin (Quarterly) | -10.00K% |
| Return on Net Operating Assets | -329.7% |